TotalEnergies SE vs GeneDx Holdings Corp — how do they compare? TotalEnergies SE trades at $87 (market cap $193.30B), while GeneDx Holdings Corp trades at $78.16 (market cap $2.45B). The key difference: TotalEnergies SE is far larger — about 78.9× GeneDx Holdings Corp's market cap, and TotalEnergies SE pays a 4.83% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| TTE | WGS | |
|---|---|---|
Market Cap | $193.30B | $2.45B |
Sector | Energy | Technology |
52-Week High | $93.60 | $167.51 |
52-Week Low | $57.39 | $34.51 |
Enterprise Value | $224.29B | $2.49B |
Dividend Yield | 4.83% | — |
Signals from Pluang's Aura AI — not financial advice
TotalEnergies (TTE) trades at $87.05, down 1.02% in the last session, with a bullish technical signal from moving averages and a consensus price target of $94.00. Recent earnings show mixed results, with Q2 2026 beating estimates but Q4 2025 missing. The company is expanding in renewables, acquiring Shell's European onshore renewables unit and partnering on a Cyprus gas field, while facing a climate-related legal appeal in France.
The outlook is positive due to low valuation multiples (P/E of 10.98) and strong cash flow, but risks include declining revenue trends and regulatory pressures. Analyst consensus is bullish with 57.58% buy ratings, suggesting potential upside from current levels amid energy market volatility.
GeneDx Holdings Corp (WGS) trades at $82.39, up 0.8% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS versus a projected loss, and revenue reached $114.4 million. However, the company shows negative net income margins and high valuation multiples, alongside ongoing class action lawsuits creating headwinds.
The outlook is mixed: robust revenue growth and institutional buying signal potential, but profitability challenges and legal risks warrant caution. With a consensus price target of $79.25 below the current price, near-term pressure may persist despite long-term optimism from 91% buy ratings.
Trailing returns across standard periods
Latest headlines on both assets
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →